Yinyan Wang , Yang Wang , Hongbo Bao , Zihan Wang , Tao Jiang
{"title":"Mechanisms and therapeutic implications of glioma-neuron interactions","authors":"Yinyan Wang , Yang Wang , Hongbo Bao , Zihan Wang , Tao Jiang","doi":"10.1016/j.canlet.2025.217884","DOIUrl":null,"url":null,"abstract":"<div><div>Glioma is the most common type of primary brain tumor and is almost always fatal. The challenge to develop more effective treatments lies in its high invasiveness and solid intratumoral heterogeneity, as well as its insensitivity to traditional radiotherapy and chemotherapy. With the rise of cancer neuroscience, mounting evidence has uncovered a multi-layered and dynamically complex network of communication between glioma cells and neurons which has given us new insights into tumor progression. The nervous system is now recognized as not merely a passive victim of tumor invasion, but as an active modulator and perhaps even driver of glioma progression. In this review, we systematically summarize the interaction of glioma with neuron mechanisms, including synaptic, electrophysiological, paracrine, metabolic, and neurotransmitter-related pathways. In addition, we investigate the extent to which these interactions are associated with gliomas and reveal their potential as therapeutic targets, thereby offering a theoretical foundation and new strategies for the precision treatment of glioma. Taken together, the cross-talk between gliomas and neurons is a dynamic, multi-level, multi-pathway co-regulated network system. Further exploration of this network may promote transformation from a tumor-focused to a tumor-neuron network-based therapeutic plan and provide new prospects for precision medicine.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"629 ","pages":"Article 217884"},"PeriodicalIF":9.1000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525004525","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Glioma is the most common type of primary brain tumor and is almost always fatal. The challenge to develop more effective treatments lies in its high invasiveness and solid intratumoral heterogeneity, as well as its insensitivity to traditional radiotherapy and chemotherapy. With the rise of cancer neuroscience, mounting evidence has uncovered a multi-layered and dynamically complex network of communication between glioma cells and neurons which has given us new insights into tumor progression. The nervous system is now recognized as not merely a passive victim of tumor invasion, but as an active modulator and perhaps even driver of glioma progression. In this review, we systematically summarize the interaction of glioma with neuron mechanisms, including synaptic, electrophysiological, paracrine, metabolic, and neurotransmitter-related pathways. In addition, we investigate the extent to which these interactions are associated with gliomas and reveal their potential as therapeutic targets, thereby offering a theoretical foundation and new strategies for the precision treatment of glioma. Taken together, the cross-talk between gliomas and neurons is a dynamic, multi-level, multi-pathway co-regulated network system. Further exploration of this network may promote transformation from a tumor-focused to a tumor-neuron network-based therapeutic plan and provide new prospects for precision medicine.
期刊介绍:
Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research.
Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy.
By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.